ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,280,000 | -55.1% | 47,035 | -60.9% | 0.48% | -68.4% |
| Q1 2020 | $5,079,000 | -1.4% | 120,216 | -0.1% | 1.53% | +44.9% |
| Q4 2019 | $5,150,000 | +47.1% | 120,386 | +23.8% | 1.06% | +13.6% |
| Q3 2019 | $3,500,000 | +288.0% | 97,239 | +188.1% | 0.93% | +303.0% |
| Q2 2019 | $902,000 | -44.0% | 33,746 | -43.8% | 0.23% | -48.9% |
| Q1 2019 | $1,611,000 | +0.8% | 60,009 | -39.3% | 0.45% | -13.9% |
| Q4 2018 | $1,598,000 | -17.1% | 98,806 | +6.4% | 0.52% | -5.6% |
| Q3 2018 | $1,928,000 | +79.3% | 92,885 | +160.2% | 0.56% | -36.2% |
| Q4 2017 | $1,075,000 | -1.3% | 35,701 | +23.5% | 0.87% | -22.2% |
| Q3 2017 | $1,089,000 | +109.8% | 28,919 | +55.4% | 1.12% | +73.1% |
| Q2 2017 | $519,000 | -14.6% | 18,615 | -2.6% | 0.65% | +53.0% |
| Q3 2016 | $608,000 | – | 19,110 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |